Akèy › Maladi Parkinson › Kansas
Etid klinik pou Maladi Parkinson nan Kansas
10 etid pou Maladi Parkinson ap chèche patisipan nan sit nan Kansas.
Vil nan Kansas
Tèks ofisyèl etid la (Anglè)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06680830A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-029, Kansas City
Ap rekriteFaz 2/3
Laj 40 a 80 · Tout sèks · Mizajou Sep 28, 2026 · NCT06976268A Study of Buntanetap in Participants With PD
- University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D, Kansas City
Ap rekriteFaz 2/3
Laj 40 a 85 · Tout sèks · Mizajou Sep 21, 2026 · NCT07284784A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #041, Overland Park
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- The University of Kansas (KU) (Site #216), Kansas City
Ap rekriteFaz 2
Laj 30 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of Kansas, Lawrence
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT04994015A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 3, 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 3
Laj 45 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Kansas Medical Center, Kansas City
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04477785A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2025 · NCT06765668Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.